KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.30 $2.47 Friday, 26th Apr 2024 AKBA stock ended at $1.34. This is 0.752% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 4.25% from a day low at $1.30 to a day high of $1.35.
90 days $1.30 $2.47
52 weeks $0.780 $2.47

Historical Akebia Therapeutics prices

Date Open High Low Close Volume
Aug 16, 2022 $0.420 $0.430 $0.400 $0.417 3 069 278
Aug 15, 2022 $0.409 $0.416 $0.406 $0.414 1 953 644
Aug 12, 2022 $0.398 $0.418 $0.398 $0.413 2 086 603
Aug 11, 2022 $0.415 $0.420 $0.395 $0.399 3 166 455
Aug 10, 2022 $0.395 $0.420 $0.390 $0.416 3 669 430
Aug 09, 2022 $0.405 $0.405 $0.380 $0.405 5 432 474
Aug 08, 2022 $0.400 $0.419 $0.394 $0.405 4 912 356
Aug 05, 2022 $0.398 $0.410 $0.390 $0.395 6 754 880
Aug 04, 2022 $0.410 $0.420 $0.392 $0.410 9 997 843
Aug 03, 2022 $0.371 $0.403 $0.371 $0.391 7 551 376
Aug 02, 2022 $0.379 $0.390 $0.365 $0.371 8 344 063
Aug 01, 2022 $0.391 $0.407 $0.380 $0.384 2 647 094
Jul 29, 2022 $0.400 $0.408 $0.385 $0.391 4 669 187
Jul 28, 2022 $0.411 $0.411 $0.391 $0.399 1 277 318
Jul 27, 2022 $0.417 $0.419 $0.400 $0.413 1 089 680
Jul 26, 2022 $0.400 $0.415 $0.390 $0.405 2 043 779
Jul 25, 2022 $0.420 $0.429 $0.396 $0.402 3 502 317
Jul 22, 2022 $0.450 $0.451 $0.414 $0.425 2 485 455
Jul 21, 2022 $0.442 $0.453 $0.426 $0.443 2 513 138
Jul 20, 2022 $0.408 $0.459 $0.408 $0.442 5 479 325
Jul 19, 2022 $0.417 $0.430 $0.400 $0.411 2 964 059
Jul 18, 2022 $0.420 $0.429 $0.394 $0.402 3 112 233
Jul 15, 2022 $0.421 $0.438 $0.410 $0.422 3 282 792
Jul 14, 2022 $0.440 $0.450 $0.429 $0.435 3 888 710
Jul 13, 2022 $0.414 $0.467 $0.414 $0.448 5 187 328
Click to get the best stock tips daily for free!

About Akebia Therapeutics

Akebia Therapeutics Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent adult patients. It also offers Auryxia, a ferric citra... AKBA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT